The One Dewormer Proven to Reach Encysted Strongyles
Your horse may look fine on the outside. But beneath the surface, encysted larvae are waiting — dormant, protected, and invisible to most dewormers. Panacur's fenbendazole reaches the stage of the parasite lifecycle your current rotation almost certainly misses.
The Problem
Your Horse Is Dewormed on Schedule — So Why Does He Still Seem Off?
You've been rotating dewormers faithfully. Every eight weeks, like clockwork — you've read the articles, followed the schedule, done everything the experienced rider at your barn told you to do. But come winter, your gelding loses topline faster than you'd expect. His coat loses a little luster. He's just slightly less bright in the eye, slightly less forward under saddle. Nothing you can put your finger on, but something that nags at you.
You mention it to your barn manager. She nods slowly. She's seen it before — horses dewormed on schedule that still don't quite thrive. She tells you about a mare two barns over, dewormed every other month for three years, who came up with a fecal egg count that didn't add up. How do you fight something you can't see?
The frustration compounds in spring. You've increased hay, added a vitamin supplement, called the dentist, the chiro, the saddle fitter. Your vet gives you a clean bill of health on the standard exam. And still, something is just slightly wrong. It doesn't make sense — until you start learning about the parasite lifecycle stage nobody talks about at the feed store.
Small strongyles are the most common internal parasite in adult horses worldwide. And their most dangerous form isn't the adult living in the large intestine — it's the larva burrowing into the intestinal wall, dormant, invisible, protected by the mucosal lining of the gut. Most anthelmintic compounds reach adult worms easily. What they cannot reach — what they slide right past — is the larva coiled in its cyst, quietly waiting for spring.
You mention it to your barn manager. She nods slowly. She's seen it before — horses dewormed on schedule that still don't quite thrive. She tells you about a mare two barns over, dewormed every other month for three years, who came up with a fecal egg count that didn't add up. How do you fight something you can't see?
The frustration compounds in spring. You've increased hay, added a vitamin supplement, called the dentist, the chiro, the saddle fitter. Your vet gives you a clean bill of health on the standard exam. And still, something is just slightly wrong. It doesn't make sense — until you start learning about the parasite lifecycle stage nobody talks about at the feed store.
Small strongyles are the most common internal parasite in adult horses worldwide. And their most dangerous form isn't the adult living in the large intestine — it's the larva burrowing into the intestinal wall, dormant, invisible, protected by the mucosal lining of the gut. Most anthelmintic compounds reach adult worms easily. What they cannot reach — what they slide right past — is the larva coiled in its cyst, quietly waiting for spring.
Why It Keeps Happening
One Reason Standard Dewormers Keep Coming Up Short
The most common deworming mistake isn't rotating too slowly or skipping a treatment. It's assuming that because an active ingredient works on adult worms, it must be working on every stage of every parasite. That assumption has cost a lot of horses their health — and cost a lot of owners years of puzzling over the same low-grade symptoms with no clear answer.
Here's what the lifecycle actually looks like. A horse grazes, ingests strongyle larvae from the pasture. Most of those larvae will eventually mature into adult worms in the large intestine — and those adults are relatively easy to kill with a standard dose of any broad-spectrum dewormer. But some of them — and this number can be in the tens of thousands — burrow into the intestinal wall and encyst. They become hypobiotic. They go dormant. They're no longer feeding, no longer moving, and no longer vulnerable to the mechanism of action that kills adults.
Ivermectin, moxidectin, pyrantel, oxibendazole — all have real strengths in parts of the parasite spectrum. Ivermectin and moxidectin dominate for bots and large strongyles. Pyrantel is excellent against pinworms. But none of them reliably reach encysted small strongyle larvae at standard doses. Even moxidectin, which has some efficacy against early third-stage larvae, is not consistently effective against the full encysted population. The result: you rotate dutifully, and the encysted burden quietly builds, season after season.
Encysted small strongyle burden peaks in winter and early spring — precisely when horses are already managing cold stress, reduced turnout, and the demands of growing a winter coat. When those larvae begin emerging en masse in late winter, the immune response and gut inflammation can be severe. It's called larval cyathostominosis, and it can present as sudden weight loss, diarrhea, colic, and protein-losing enteropathy. The horses hit hardest are often the ones whose owners thought they were doing everything right.
Here's what the lifecycle actually looks like. A horse grazes, ingests strongyle larvae from the pasture. Most of those larvae will eventually mature into adult worms in the large intestine — and those adults are relatively easy to kill with a standard dose of any broad-spectrum dewormer. But some of them — and this number can be in the tens of thousands — burrow into the intestinal wall and encyst. They become hypobiotic. They go dormant. They're no longer feeding, no longer moving, and no longer vulnerable to the mechanism of action that kills adults.
Ivermectin, moxidectin, pyrantel, oxibendazole — all have real strengths in parts of the parasite spectrum. Ivermectin and moxidectin dominate for bots and large strongyles. Pyrantel is excellent against pinworms. But none of them reliably reach encysted small strongyle larvae at standard doses. Even moxidectin, which has some efficacy against early third-stage larvae, is not consistently effective against the full encysted population. The result: you rotate dutifully, and the encysted burden quietly builds, season after season.
Encysted small strongyle burden peaks in winter and early spring — precisely when horses are already managing cold stress, reduced turnout, and the demands of growing a winter coat. When those larvae begin emerging en masse in late winter, the immune response and gut inflammation can be severe. It's called larval cyathostominosis, and it can present as sudden weight loss, diarrhea, colic, and protein-losing enteropathy. The horses hit hardest are often the ones whose owners thought they were doing everything right.
The Solution
The Answer Lives in the Active Ingredient Your Rotation Has Been Missing
Fenbendazole — the active ingredient in Panacur — works differently than the macrocyclic lactone compounds that dominate most deworming rotations. Its mechanism of action targets tubulin polymerization in the parasite's cellular structure, disrupting motility and metabolism in ways that reach stages other compounds routinely miss. At a single-dose level, it's a highly effective broad-spectrum dewormer. At a five-day elevated-dose protocol, it becomes one of the only tools available to target encysted small strongyle larvae directly.
That five-day larvicidal dose is what sets fenbendazole apart in clinical use. At 10 mg/kg body weight administered daily for five consecutive days, Panacur's fenbendazole penetrates the intestinal mucosal barrier and reaches the encysted larvae that standard one-dose treatment leaves untouched. Research in equine parasitology literature has shown fecal egg count reductions that extend well beyond what single-dose dewormers achieve — and evidence of meaningfully reduced larval burden compared to controls treated with other compounds. This isn't marketing. It's mechanism of action.
The 25-gram syringe format makes dosing practical and accurate. One syringe contains enough fenbendazole to treat a horse weighing up to 1,100 pounds — covering the vast majority of adult horses. The dial-ring dosing mechanism is straightforward to set and administer, and the apple-cinnamon flavor means acceptance is rarely a battle. For foals and weanlings under 18 months, where ascarids are the primary concern, the protocol calls for one syringe per 550 pounds per day for five consecutive days. Panacur is cleared for use in foals, breeding stallions, and pregnant mares — a safety profile that many other active ingredients simply cannot match.
Schneider Saddlery has carried Panacur for decades — not because it's the newest product on the shelf, but because it remains one of the most clinically important tools in equine parasite management. Our customers who ask why their horses aren't responding to their rotation almost always haven't incorporated fenbendazole's five-day dose into their annual calendar. When they do, the difference shows in condition, topline, coat quality, and fecal egg count reductions that finally hold where single-dose products have fallen short.
That five-day larvicidal dose is what sets fenbendazole apart in clinical use. At 10 mg/kg body weight administered daily for five consecutive days, Panacur's fenbendazole penetrates the intestinal mucosal barrier and reaches the encysted larvae that standard one-dose treatment leaves untouched. Research in equine parasitology literature has shown fecal egg count reductions that extend well beyond what single-dose dewormers achieve — and evidence of meaningfully reduced larval burden compared to controls treated with other compounds. This isn't marketing. It's mechanism of action.
The 25-gram syringe format makes dosing practical and accurate. One syringe contains enough fenbendazole to treat a horse weighing up to 1,100 pounds — covering the vast majority of adult horses. The dial-ring dosing mechanism is straightforward to set and administer, and the apple-cinnamon flavor means acceptance is rarely a battle. For foals and weanlings under 18 months, where ascarids are the primary concern, the protocol calls for one syringe per 550 pounds per day for five consecutive days. Panacur is cleared for use in foals, breeding stallions, and pregnant mares — a safety profile that many other active ingredients simply cannot match.
Schneider Saddlery has carried Panacur for decades — not because it's the newest product on the shelf, but because it remains one of the most clinically important tools in equine parasite management. Our customers who ask why their horses aren't responding to their rotation almost always haven't incorporated fenbendazole's five-day dose into their annual calendar. When they do, the difference shows in condition, topline, coat quality, and fecal egg count reductions that finally hold where single-dose products have fallen short.
🛡️
Encysted Larva Coverage
Fenbendazole is one of the only active ingredients proven to reach dormant, encysted small strongyle larvae buried in the intestinal wall — the stage most rotations miss entirely.
🐴
Safe for Every Horse
Approved for use in foals, weanlings, pregnant mares, and breeding stallions — making Panacur the most broadly safe dewormer you can add to your annual program.
Side by Side
How We Stack Up
| Feature | Schneiders [Product Name] |
|---|
Targeted Parasite Control Your Rotation Has Been Missing
Warmth: Default Title
Size:
Color:
Ready to Order?
Give Your Horse the Coverage That Reaches Every Parasite Stage
Panacur's 10% fenbendazole formula is the only tool in a standard deworming rotation proven to address encysted small strongyle larvae — the silent burden most horses carry through winter. Schneider Saddlery has stocked trusted equine health products for nearly 80 years because our customers depend on solutions that actually work. Add Panacur to your annual program today and finally address the parasite stage your rotation has been missing.
🚚 Free Shipping on $99+
↩️ Free Size Exchanges
🔒 Secure Checkout